Novo Holdings A/S - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$4,719,600
-48.7%
360,0000.0%0.35%
-51.0%
Q2 2023$9,208,800
-32.3%
360,000
-33.3%
0.71%
-20.6%
Q1 2023$13,602,600
-7.2%
540,000
-15.3%
0.90%
-2.0%
Q4 2022$14,651,918
+12.8%
637,317
+8.3%
0.92%
+47.8%
Q3 2022$12,984,000
+53.9%
588,3080.0%0.62%
+49.2%
Q2 2022$8,436,000
-10.9%
588,308
+17.6%
0.42%
-16.8%
Q1 2022$9,463,000
+1.4%
500,4210.0%0.50%
+12.9%
Q4 2021$9,328,000
+22.2%
500,421
+76.3%
0.44%
+11.9%
Q3 2021$7,633,000
-24.4%
283,769
-12.1%
0.40%
-11.8%
Q2 2021$10,097,000323,0000.45%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders